SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-24-097023
Filing Date
2024-04-16
Accepted
2024-04-16 08:00:37
Documents
16
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d816715d10ka.htm   iXBRL 10-K/A 422794
2 EX-31.2 d816715dex312.htm EX-31.2 4288
  Complete submission text file 0001193125-24-097023.txt   688478

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA labp-20231231.xsd EX-101.SCH 4620
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE labp-20231231_cal.xml EX-101.CAL 687
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE labp-20231231_def.xml EX-101.DEF 17091
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE labp-20231231_lab.xml EX-101.LAB 23082
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE labp-20231231_pre.xml EX-101.PRE 18648
19 EXTRACTED XBRL INSTANCE DOCUMENT d816715d10ka_htm.xml XML 9557
Mailing Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060
Business Address 1800 KRAFT DRIVE, SUITE 216 BLACKSBURG VA 24060 540-818-2844
Landos Biopharma, Inc. (Filer) CIK: 0001785345 (see all company filings)

IRS No.: 815085535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39971 | Film No.: 24846137
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)